Specific Profiles and Amplification of Resistance to Anti-tuberculosis Drugs in Tuberculosis Patients in the Republic of Karelia

The objective: to determine the frequency of resistance of Mycobacterium tuberculosis (MTB) to the most effective anti-tuberculosis drugs in tuberculosis patients in the Republic of Karelia, to characterize cases of amplification of MTB drug resistance during chemotherapy (CT).Subjects and Methods....

Full description

Saved in:
Bibliographic Details
Main Authors: Yu. M. Markelov, E. N. Belyaeva, T. V. Sunchalina
Format: Article
Language:Russian
Published: New Terra Publishing House 2022-10-01
Series:Туберкулез и болезни лёгких
Subjects:
Online Access:https://www.tibl-journal.com/jour/article/view/1673
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849771268789764096
author Yu. M. Markelov
E. N. Belyaeva
T. V. Sunchalina
author_facet Yu. M. Markelov
E. N. Belyaeva
T. V. Sunchalina
author_sort Yu. M. Markelov
collection DOAJ
description The objective: to determine the frequency of resistance of Mycobacterium tuberculosis (MTB) to the most effective anti-tuberculosis drugs in tuberculosis patients in the Republic of Karelia, to characterize cases of amplification of MTB drug resistance during chemotherapy (CT).Subjects and Methods. MTB cultures of 1,137 tuberculosis patients were studied, the patients received chemotherapy from 2016 to 2021, among them 634 (55.8%) had multiple drug resistance (MDR). Among MBT cultures with MDR, there was a high frequency of MTB with extensive drug resistance (XDR) – 42.3% (268/634) including new cases. It provided a negative impact on the chemotherapy efficacy. Most often, amplification of MTB drug resistance was observed in patients treated as per regimen IV – 37/49 (75.5%) cases. MTB drug resistance amplified more often in the cases who were already resistant to 3 and more anti-tuberculosis drugs, 31/49 (63.3%). Most often, amplification was noted in aminoglycosides (Km, Am) and glycopeptide (Cm), (71.6% of cases). The high frequency of MTB drug resistance amplification from MDR up to XDR was due to the lack of rapid molecular genetic methods to test drug susceptibility to fluoroquinolones and aminoglycosides.
format Article
id doaj-art-6074c8a6b046489ea1bbf49ae2c16c68
institution DOAJ
issn 2075-1230
2542-1506
language Russian
publishDate 2022-10-01
publisher New Terra Publishing House
record_format Article
series Туберкулез и болезни лёгких
spelling doaj-art-6074c8a6b046489ea1bbf49ae2c16c682025-08-20T03:02:41ZrusNew Terra Publishing HouseТуберкулез и болезни лёгких2075-12302542-15062022-10-011009212610.21292/2075-1230-2022-100-9-21-261668Specific Profiles and Amplification of Resistance to Anti-tuberculosis Drugs in Tuberculosis Patients in the Republic of KareliaYu. M. Markelov0E. N. Belyaeva1T. V. Sunchalina2Petrozavodsk State University; Republican TB Dispensary, the Republic of KareliaPetrozavodsk State University; Republican TB Dispensary, the Republic of KareliaPetrozavodsk State University; Republican TB Dispensary, the Republic of KareliaThe objective: to determine the frequency of resistance of Mycobacterium tuberculosis (MTB) to the most effective anti-tuberculosis drugs in tuberculosis patients in the Republic of Karelia, to characterize cases of amplification of MTB drug resistance during chemotherapy (CT).Subjects and Methods. MTB cultures of 1,137 tuberculosis patients were studied, the patients received chemotherapy from 2016 to 2021, among them 634 (55.8%) had multiple drug resistance (MDR). Among MBT cultures with MDR, there was a high frequency of MTB with extensive drug resistance (XDR) – 42.3% (268/634) including new cases. It provided a negative impact on the chemotherapy efficacy. Most often, amplification of MTB drug resistance was observed in patients treated as per regimen IV – 37/49 (75.5%) cases. MTB drug resistance amplified more often in the cases who were already resistant to 3 and more anti-tuberculosis drugs, 31/49 (63.3%). Most often, amplification was noted in aminoglycosides (Km, Am) and glycopeptide (Cm), (71.6% of cases). The high frequency of MTB drug resistance amplification from MDR up to XDR was due to the lack of rapid molecular genetic methods to test drug susceptibility to fluoroquinolones and aminoglycosides.https://www.tibl-journal.com/jour/article/view/1673multiple and extensive drug resistance of mycobacterium tuberculosisamplification of drug resistance
spellingShingle Yu. M. Markelov
E. N. Belyaeva
T. V. Sunchalina
Specific Profiles and Amplification of Resistance to Anti-tuberculosis Drugs in Tuberculosis Patients in the Republic of Karelia
Туберкулез и болезни лёгких
multiple and extensive drug resistance of mycobacterium tuberculosis
amplification of drug resistance
title Specific Profiles and Amplification of Resistance to Anti-tuberculosis Drugs in Tuberculosis Patients in the Republic of Karelia
title_full Specific Profiles and Amplification of Resistance to Anti-tuberculosis Drugs in Tuberculosis Patients in the Republic of Karelia
title_fullStr Specific Profiles and Amplification of Resistance to Anti-tuberculosis Drugs in Tuberculosis Patients in the Republic of Karelia
title_full_unstemmed Specific Profiles and Amplification of Resistance to Anti-tuberculosis Drugs in Tuberculosis Patients in the Republic of Karelia
title_short Specific Profiles and Amplification of Resistance to Anti-tuberculosis Drugs in Tuberculosis Patients in the Republic of Karelia
title_sort specific profiles and amplification of resistance to anti tuberculosis drugs in tuberculosis patients in the republic of karelia
topic multiple and extensive drug resistance of mycobacterium tuberculosis
amplification of drug resistance
url https://www.tibl-journal.com/jour/article/view/1673
work_keys_str_mv AT yummarkelov specificprofilesandamplificationofresistancetoantituberculosisdrugsintuberculosispatientsintherepublicofkarelia
AT enbelyaeva specificprofilesandamplificationofresistancetoantituberculosisdrugsintuberculosispatientsintherepublicofkarelia
AT tvsunchalina specificprofilesandamplificationofresistancetoantituberculosisdrugsintuberculosispatientsintherepublicofkarelia